Intelligence Β· Patent portfolio
Takeda Patents
Full USPTO pharma patent portfolio for Takeda β grant dates, expiration, and drug cross-links.
- Patents
- 1,436
- Expiring β€24m
- 81
Quick answer
Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months β use filters for patent-cliff planning.
-
US 6632807
(2R,4S)-(−)-[N-(4-diethoxyphosphorylmethyl)phenyl]-1,2,4,5- tetrahydro-4-methyl-7,8-methylenedioxy-5-oxo-3-benzothiepin-2-carboxamide
expired -
US 6627630
Condensed pyridazine derivatives, their production and use
expired -
US 6627651
Cyclic compounds and uses thereof
expired -
US 6620825
Adenosine A3 receptor antagonists
expired -
US 6613761
Benzoxazepine compounds, their production and use
expired -
US 6613805
Amine compounds, their production and use
expired -
US 6613887
Human ependymin-like protein
expired -
US 6610655
Pentapeptide with specific conformation, its production and use
expired -
US 6608092
Crystals of benzimidazole compounds
expired -
US 6608210
Benzimidazole derivatives, their production and use
expired -
US 6605629
Neurotrophin production secretion promoting agent
expired -
US 6599923
Pharmaceutical composition
expired -
US 6590090
Fas ligand-like protein, its production and use
expired -
US 6589547
Sustained-release preparation for AII antagonist, production and use thereof
expired -
US 6586004
Solid preparation
expired -
US 6586475
&bgr;-amyloid protein production/secretion inhibitors
expired -
US 6583146
Thiazolopyrimidine compounds, its production and use
expired -
US 6583164
Antimycotic drug composition
expired -
US 6573289
Naphthalene derivatives, their production and use
expired -
US 6566116
Matrix metalloprotease
expired -
US 6562978
Cyclic amine compounds as CCR5 antagonists
expired -
US 6555565
Apoptosis inhibitor
expired -
US 6552054
Chromone derivatives, process for the preparation of the same and uses thereof
expired -
US 6552058
Oxazolidinedione derivatives and their use
expired -
US 6545009
Retinoid-related receptor function regulating agent
expired -
US 6534496
Thermogenic composition and benzazepine thermogenics
expired -
US 6531604
Benzothiepine derivatives, their production and use
expired -
US 6528093
Sustained-release preparation
expired -
US 6521256
Stabilized pharmaceutical composition
expired -
US 6518257
1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof
expired -
US 6518435
Process for the preparation of oxyiminoalkanoic acid derivatives
expired -
US 6514962
Stabilized preparations of &bgr;-lactam antibiotic
expired -
US 6514988
Condensed-ring thiophene derivatives, their production and use
expired -
US 6503918
D-mannitol and its preparation
expired -
US 6500820
Pharmaceutical composition for neurotrophic action
expired -
US 6498019
Lecithin-cholesterol acyltransferase protein
expired -
US 6495581
Oxyiminoalkanoic acid derivatives
expired -
US 6495604
Cycloalkene derivatives, process for producing the same, and use
expired -
US 6492324
APJ ligand polypeptides
expired -
US 6489315
Cyclic compounds, their production and use
expired -
US 6482864
Sustained-release preparation of physiologically active polypeptide and production thereof
expired -
US 6479536
Benzofuran derivatives, process for the preparation of the same and uses thereof
expired -
US 6469037
Prophylactic or therapeutic drug for renal diseases
expired -
US 6462058
Benzimidazole compound crystal
expired -
US 6440946
Multiple-agents-binding compound, production and use thereof
expired -
US 6436966
Adenosine A3 receptor antagonists
expired -
US 6432996
Pharmaceutical composition
expired -
US 6429296
Complex of human growth hormone and zinc and use
expired
Frequently asked questions
How many patents does Takeda have?
1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Takeda patents expire?
81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory